- Home
- PBT vs OPK Comparison
PBT vs OPK Comparison
Compare PBT & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PBT | OPK |
|---|---|---|
| Founded | 1980 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 946.2M | 921.2M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | PBT | OPK |
|---|---|---|
| Price | $20.81 | $1.17 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $2.03 |
| AVG Volume (30 Days) | 85.6K | ★ 2.0M |
| Earning Date | 03-13-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.57% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $606,879,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.76 |
| P/E Ratio | $57.37 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.01 | $1.11 |
| 52 Week High | $21.42 | $1.86 |
Technical Indicators
Market Signals| Indicator | PBT | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 60.57 | 42.54 |
| Support Level | $17.78 | $1.12 |
| Resistance Level | N/A | $1.27 |
| Average True Range (ATR) | 0.77 | 0.04 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 73.96 | 25.00 |
Price Performance
Historical ComparisonAbout PBT Permian Basin Royalty Trust
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.